In hypertensive patients aged 60 to 80 years, does more intensive antihypertensive treatment reduce cardiovascular events compared to standard treatment while being safe?
Gespeichert in:
| Veröffentlicht in: | La revue de medecine interne 2022-02, Vol.43 (2), p.128-129 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 129 |
|---|---|
| container_issue | 2 |
| container_start_page | 128 |
| container_title | La revue de medecine interne |
| container_volume | 43 |
| creator | Lanthier, L Lauzon, D Plourde, M-É Cauchon, M |
| description | |
| doi_str_mv | 10.1016/j.revmed.2021.12.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2618903116</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618903116</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-6f5328f5712f2213eb6ebfaca1a0749512e838441ecd1510a4b31bfdd5b11d623</originalsourceid><addsrcrecordid>eNpVkctKA0EQRRtBTIz-gUgvXZixq3teWYkEH4GAG10PNdM1SYd52d0Tyd_4AX6FX-agCejqbs49F6oYuwARgID4ZhNY2takAykkBCADIeQRG0MSp1MFUo7YqXMbIcRAz07YSEUCZJLOxuxz0fD1riPrqXFmS7xDb6jxjuOKNI_F14dveTrEjtC6a65bcrxuLXHTHDrYePNP4i2hrwcNt6T7gniBVpt2i67oK7Sctj8TRVt3OBB8mHAeGz1Qf7rva1MRz8k0K-6wpNszdlxi5eh8nxP2-nD_Mn-aLp8fF_O75bSDEPw0LiMl0zJKQJZSgqI8przEAgFFEs4ikJSqNAyBCg0RCAxzBXmpdZQD6FiqCbv69Xa2fevJ-aw2rqCqwoba3mUyhnQmFEA8oJd7tM-HB2SdNTXaXXa4sPoGjMWDPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618903116</pqid></control><display><type>article</type><title>In hypertensive patients aged 60 to 80 years, does more intensive antihypertensive treatment reduce cardiovascular events compared to standard treatment while being safe?</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Lanthier, L ; Lauzon, D ; Plourde, M-É ; Cauchon, M</creator><creatorcontrib>Lanthier, L ; Lauzon, D ; Plourde, M-É ; Cauchon, M</creatorcontrib><identifier>EISSN: 1768-3122</identifier><identifier>DOI: 10.1016/j.revmed.2021.12.002</identifier><identifier>PMID: 35012789</identifier><language>fre</language><publisher>France</publisher><subject>Aged ; Aged, 80 and over ; Antihypertensive Agents - therapeutic use ; Blood Pressure ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - prevention & control ; Humans ; Hypertension - drug therapy ; Hypertension - epidemiology ; Middle Aged ; Treatment Outcome</subject><ispartof>La revue de medecine interne, 2022-02, Vol.43 (2), p.128-129</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35012789$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lanthier, L</creatorcontrib><creatorcontrib>Lauzon, D</creatorcontrib><creatorcontrib>Plourde, M-É</creatorcontrib><creatorcontrib>Cauchon, M</creatorcontrib><title>In hypertensive patients aged 60 to 80 years, does more intensive antihypertensive treatment reduce cardiovascular events compared to standard treatment while being safe?</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Blood Pressure</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Middle Aged</subject><subject>Treatment Outcome</subject><issn>1768-3122</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctKA0EQRRtBTIz-gUgvXZixq3teWYkEH4GAG10PNdM1SYd52d0Tyd_4AX6FX-agCejqbs49F6oYuwARgID4ZhNY2takAykkBCADIeQRG0MSp1MFUo7YqXMbIcRAz07YSEUCZJLOxuxz0fD1riPrqXFmS7xDb6jxjuOKNI_F14dveTrEjtC6a65bcrxuLXHTHDrYePNP4i2hrwcNt6T7gniBVpt2i67oK7Sctj8TRVt3OBB8mHAeGz1Qf7rva1MRz8k0K-6wpNszdlxi5eh8nxP2-nD_Mn-aLp8fF_O75bSDEPw0LiMl0zJKQJZSgqI8przEAgFFEs4ikJSqNAyBCg0RCAxzBXmpdZQD6FiqCbv69Xa2fevJ-aw2rqCqwoba3mUyhnQmFEA8oJd7tM-HB2SdNTXaXXa4sPoGjMWDPw</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Lanthier, L</creator><creator>Lauzon, D</creator><creator>Plourde, M-É</creator><creator>Cauchon, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202202</creationdate><title>In hypertensive patients aged 60 to 80 years, does more intensive antihypertensive treatment reduce cardiovascular events compared to standard treatment while being safe?</title><author>Lanthier, L ; Lauzon, D ; Plourde, M-É ; Cauchon, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-6f5328f5712f2213eb6ebfaca1a0749512e838441ecd1510a4b31bfdd5b11d623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Blood Pressure</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Middle Aged</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lanthier, L</creatorcontrib><creatorcontrib>Lauzon, D</creatorcontrib><creatorcontrib>Plourde, M-É</creatorcontrib><creatorcontrib>Cauchon, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lanthier, L</au><au>Lauzon, D</au><au>Plourde, M-É</au><au>Cauchon, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In hypertensive patients aged 60 to 80 years, does more intensive antihypertensive treatment reduce cardiovascular events compared to standard treatment while being safe?</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2022-02</date><risdate>2022</risdate><volume>43</volume><issue>2</issue><spage>128</spage><epage>129</epage><pages>128-129</pages><eissn>1768-3122</eissn><cop>France</cop><pmid>35012789</pmid><doi>10.1016/j.revmed.2021.12.002</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1768-3122 |
| ispartof | La revue de medecine interne, 2022-02, Vol.43 (2), p.128-129 |
| issn | 1768-3122 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_2618903116 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
| subjects | Aged Aged, 80 and over Antihypertensive Agents - therapeutic use Blood Pressure Cardiovascular Diseases - drug therapy Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Humans Hypertension - drug therapy Hypertension - epidemiology Middle Aged Treatment Outcome |
| title | In hypertensive patients aged 60 to 80 years, does more intensive antihypertensive treatment reduce cardiovascular events compared to standard treatment while being safe? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A43%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20hypertensive%20patients%20aged%2060%C2%A0to%2080%C2%A0years,%20does%20more%20intensive%20antihypertensive%20treatment%20reduce%20cardiovascular%20events%20compared%20to%20standard%20treatment%20while%20being%20safe?&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Lanthier,%20L&rft.date=2022-02&rft.volume=43&rft.issue=2&rft.spage=128&rft.epage=129&rft.pages=128-129&rft.eissn=1768-3122&rft_id=info:doi/10.1016/j.revmed.2021.12.002&rft_dat=%3Cproquest_pubme%3E2618903116%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2618903116&rft_id=info:pmid/35012789&rfr_iscdi=true |